For millions of people living with Type 1 Diabetes (T1D) around the world, the daily reality is shaped not just by their diagnosis, but by where they live, their income level, and the strength of their local healthcare system. While T1D is a global health challenge, access to life-saving insulin, monitoring technology, and specialized care remains profoundly unequal. JDRF, formerly the Juvenile Diabetes Research Foundation, has emerged as a pivotal force in the fight to close these gaps. Through targeted research funding, advocacy, and large-scale global access programs, JDRF is working to ensure that geography and socioeconomic status no longer dictate the quality of care a person with T1D receives.

The organization’s mission extends well beyond research into a cure. JDRF recognizes that even the most groundbreaking therapies are meaningless if they remain out of reach for the underserved. This article explores the nature of T1D disparities, JDRF’s multifaceted approach to addressing them, and the collaborative work underway to create a more equitable future for every individual affected by the condition.

Understanding Disparities in T1D Care

Disparities in T1D outcomes are not random; they are deeply rooted in systemic factors that create measurable differences in health. A person with T1D in a high-resource setting might expect a life expectancy close to the general population, whereas someone in a low-resource setting may face a drastically shortened lifespan. These inequities are driven by several interconnected barriers:

Geographic Isolation and Infrastructure Gaps

In many rural or remote areas, both in developing and developed nations, access to a specialized endocrinologist or a diabetes care team is limited. Patients often rely on general practitioners who may lack the latest training in T1D management. In low- and middle-income countries (LMICs), the challenge is starker: whole regions may have few or no endocrinologists at all. The World Health Organization (WHO) estimates that over 1.5 million people die each year from diabetes, with a significant proportion of those deaths linked to lack of access to insulin and basic care in LMICs (WHO Diabetes Fact Sheet).

The High Cost of Essential Supplies

Insulin, blood glucose test strips, continuous glucose monitors (CGMs), and insulin pumps are the staples of modern T1D management. Yet the cost of these items can be prohibitive. In some countries, insulin can consume a significant percentage of a family’s monthly income. Without consistent access to supplies, dangerous practices like rationing insulin become common, leading to life-threatening complications like diabetic ketoacidosis (DKA) and severe hypoglycemia.

Socioeconomic and Educational Barriers

Health literacy plays a critical role. Understanding how to adjust insulin doses, count carbohydrates, and recognize symptoms of high or low blood sugar requires education and support. Communities with lower levels of health literacy or limited access to diabetes education programs often see higher complication rates. Additionally, social determinants such as food insecurity, unstable housing, and lack of insurance coverage create environments where consistent T1D management is nearly impossible.

Racial and Ethnic Inequities

Even in high-income countries like the United States, racial and ethnic minorities face disparities. Data from organizations like the International Diabetes Federation (IDF) consistently show that Black and Hispanic individuals with T1D often have poorer glycemic control, higher rates of DKA at diagnosis, and less access to advanced diabetes technology compared to white peers. These disparities persist even when controlling for income and insurance, pointing to systemic biases in healthcare delivery.

The Global Landscape: Where the Need is Greatest

To appreciate the scale of the challenge, it’s helpful to understand the global distribution of T1D. Over 8.4 million people are estimated to live with T1D worldwide, with around 1.5 million of them in the United States. The prevalence is growing, particularly in regions like Africa, Asia, and South America, where incidence rates are rising rapidly.

However, the burden of poor outcomes falls disproportionately on countries with fragile health systems. A child diagnosed with T1D in sub-Saharan Africa may have a life expectancy of less than a year without consistent access to insulin and monitoring supplies. Contrast this with a child in Scandinavia, where life expectancy approaches that of the general population. This stark reality underscores the urgency of JDRF’s work. The organization’s strategy is built on the premise that no person with T1D should die or suffer needlessly simply because of where they were born.

JDRF’s Global Initiatives in Action

JDRF’s approach to addressing disparities is comprehensive, combining direct-access programs, research innovation, and large-scale advocacy. The organization operates with a clear understanding that sustainable change requires a multi-pronged strategy.

Global Access Programs: Bridging the Supply Gap

Through its Global Access Programs, JDRF partners with multinational pharmaceutical companies, local governments, and nonprofit organizations to improve the availability of essential diabetes supplies. These programs work to lower the cost of insulin and ensure steady supply chains in underserved areas. For example, JDRF has been instrumental in advocating for the WHO’s inclusion of insulin on the Model List of Essential Medicines and in promoting policies that encourage biosimilar insulin production, which can significantly lower prices. The organization also supports initiatives that distribute blood glucose meters and test strips to clinics in low-resource settings.

Funding Innovative Research for All Populations

Research funding is the cornerstone of JDRF’s mission, and the organization prioritizes studies that investigate the unique barriers faced by underserved populations. This includes research into low-cost insulin formulations, robust and affordable CGM technologies that function in high-humidity and high-temperature environments, and simplified treatment regimens that can be managed by healthcare workers with less specialized training. By directing funds toward these practical, scalable solutions, JDRF aims to make advanced care accessible everywhere. A landmark study funded by JDRF recently explored the cost-effectiveness of closed-loop insulin delivery systems in real-world settings, which included diverse populations in multiple countries, showing promising results for bridging technology gaps.

Culturally Appropriate Education Campaigns

Education is a powerful equalizer, but only when it is delivered in a way that respects local culture, language, and health beliefs. JDRF’s education campaigns are co-created with community leaders and healthcare workers in target regions. They produce materials that explain T1D management in simple, actionable terms, often using visual aids and local languages. The campaigns empower parents, teachers, and community health workers with the knowledge to support children with T1D—from recognizing the signs of DKA to administering glucagon in an emergency. In regions where traditional beliefs may clash with biomedical advice, JDRF works to build trust through dialogue and peer-to-peer support networks.

Partnerships and Community Engagement

Solving a problem as complex as global T1D disparity cannot be done in isolation. JDRF’s strength lies in its ability to forge strategic partnerships that amplify its reach and impact.

Collaborating with Governments and Policymakers

Policy change is essential for long-term sustainability. JDRF engages directly with ministries of health and parliamentary bodies to advocate for national diabetes plans that prioritize T1D. This includes pushing for government-subsidized insulin, the inclusion of diabetes supplies in national health insurance schemes, and the establishment of centralized registries to track T1D incidence and outcomes. The organization also provides technical assistance to help governments design and implement effective programs. By embedding T1D care within national health systems, JDRF ensures that progress is not dependent on short-term funding cycles.

Working with Industry and Innovators

Partnerships with pharmaceutical and medical device companies are crucial for driving down costs and improving technology. JDRF works with insulin manufacturers to encourage the production of affordable, heat-stable insulins suitable for climates without reliable refrigeration. The organization also collaborates with tech companies to develop low-cost CGMs and insulin pumps designed for durability and ease of use in low-resource settings. These partnerships often involve shared goals, such as increasing access in specific countries or running pilot programs that test new delivery models.

Grassroots Community Engagement

Effective interventions are designed with the community, not for them. JDRF invests in building local T1D support groups and training community health workers who serve as ongoing liaisons between patients and the healthcare system. These groups provide a vital support network, especially for families who may feel isolated by the condition. In many regions, these local entities are the first line of defense against misinformation and medical neglect. JDRF ensures that the voices of affected individuals are heard in all stages of program design and policy advocacy, from needs assessment to evaluation.

Impact and Future Goals: Measuring Progress

JDRF’s efforts have already begun to show measurable impact, though the organization is clear-eyed about the work that remains. Through its Global Access Programs, insulin and monitoring supplies have been distributed to thousands of children and adults in underserved areas, reducing instances of severe DKA and hospitalizations. Research breakthroughs supported by JDRF, including the generation of affordable, heat-stable insulin analogs, are beginning to transform care in hot climates where cold chain logistics are a perennial challenge.

The organization’s advocacy has also contributed to policy shifts. Several countries in Africa and Southeast Asia have integrated T1D supplies into their national essential medicines lists with JDRF’s support, which is a critical step toward sustainable access. In the United States, JDRF has been a leading voice in the fight for cap limits on insulin costs and for expanded Medicare coverage of CGMs.

A major future goal is to achieve 100% access to insulin and monitoring devices for all children with T1D by 2030, a target that aligns with the Sustainable Development Goals. To reach this ambitious target, JDRF will need to scale up every area of its work: increasing research funding for implementation science, forging new public-private partnerships, and intensifying advocacy at the highest levels of global health governance.

Other priorities for the coming decade include:

  • Expanding Telemedicine Solutions: Developing and supporting telehealth platforms that connect patients in rural or remote areas with endocrinologists and diabetes educators, reducing travel burdens.
  • Advocating for Universal Health Coverage: Pushing for T1D to be explicitly covered in national universal health coverage packages, so that financial protection is a given.
  • Strengthening Local Healthcare Systems: Providing grants and technical support to build local capacity for T1D management, from training doctors and nurses to setting up specialty clinics.
  • Supporting Youth and Transition Care: Focusing on the often-neglected transition from pediatric to adult care, a time when many young people fall through the cracks and experience worsening health outcomes.

How You Can Support the Movement

JDRF’s work is supported by a global community of donors, volunteers, and advocates. Individuals can contribute in several meaningful ways:

  • Donate: Financial contributions directly fund research grants, access programs, and advocacy campaigns. Even small donations can make a difference in distributing test strips or education materials to a clinic in need.
  • Advocate: Contact elected officials to voice support for policies that improve T1D access and affordability. JDRF provides toolkits and organizing resources to help make advocacy easy and effective.
  • Volunteer: Join a local JDRF chapter, participate in fundraising walks or runs, or lend professional skills (such as communications, legal, or medical expertise) to support the mission.
  • Raise Awareness: Share information on social media, in schools, and within professional networks about the global disparities in T1D care and the work being done to address them.

Toward a More Equitable Future

Type 1 Diabetes does not discriminate, but the systems designed to manage it often do. JDRF’s efforts are built on a powerful conviction: that every person with T1D, regardless of where they live or how much money they have, deserves a chance at a long and healthy life. The organization is moving beyond the traditional boundaries of research foundations to become a global catalyst for change in access and equity. The path forward is long, and the barriers are formidable, but the strides made to date prove that progress is possible when expertise, compassion, and determination come together. By continuing to support JDRF and its partners, we move closer to a world where T1D no longer dictates life’s trajectory—no matter the postal code.